Pacira BioSciences/ US6951271005 /
2024-05-15 9:59:55 PM | Chg. -0.77 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
30.07USD | -2.48% | 18,628 Turnover: 565,555.35 |
-Bid Size: - | -Ask Size: - | 31.12 | 30.02 |
GlobeNewswire
05-10
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Co...
GlobeNewswire
05-08
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of...
GlobeNewswire
05-07
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Rep...
GlobeNewswire
05-07
Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare...
GlobeNewswire
04-02
Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Con...
GlobeNewswire
03-28
Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc
GlobeNewswire
03-13
Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designati...
GlobeNewswire
03-06
Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Con...
GlobeNewswire
02-15
Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal F...
GlobeNewswire
01-03
Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire
2023-11-10
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indica...
GlobeNewswire
2023-11-07
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
GlobeNewswire
2023-10-26
Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023
GlobeNewswire
2023-10-12
American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
GlobeNewswire
2023-10-10
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors